NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, Novus Biologicals, NBP2-46127

2.57
(Overall rating from 1 review)
#4 of 10 targeting NADH dehydrogenase [ubiquinone] iron-sulfur protein 2
2.57
From 1 review · #4 of 10 for NADH dehydrogenase [ubiquinone] iron-sulfur protein 2

Information about this antibody

Catalog No
NBP2-46127
Application
N/A
Clonality
mAb
Origin
Mouse
Reactivity
N/A
Conjugation
N/A
Product Link
N/A
Clone ID
OTI1D5

Vendor notes

No vendor notes available for this antibody.

pAbmAbs Average Ratings

ℹ
Western Blot
4.24
Immunostaining
2.21
IP
1.70
Overall
2.57
Add your own rating

User Reviews (1)

Review of: NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, Bio-Techne, NBP2-46127 by pAbmAbs Data Mining

Reviewed: May 8, 2026

Our team has carried out deep research in the published scientific literature to identify papers and reports using antibodies directed against human NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 and followed up by extraction and evaluation of the available data to assess its performance according to pAbmAbs rating criteria.

YCharOS is here conducting a large head-to-head study comparing 8 commercial research antibodies against human NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 encoded by NDUFS2.

The collection of antibodies was tested using HAP1 WT and NDUFS2 KO cells in the applications WB (WT and KO cell lysates/40 µg protein), IP (WT cell lysate) and IF (WT and KO cells) according to YCharOS standard protocols (see reference).

In WB (1:2000 Ab dilution) NBP2-46127 detected a band of appr. 46 kDa in WT cell lysate with no corresponding band observed in KO cell lysate. No band was observed following IP (2 µg Ab used). In IF (1:1000 Ab dilution), comparable staining intensities were observed in both KO and WT cells.

We highly encourage other scientists to share their observations.

Western Blot
Immunostaining
IP

Submit Your Review of NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, Novus Biologicals, NBP2-46127

Please log in to submit a review.